I. Résultats and A. , Caractéristiques de la cohorte mucoviscidose à la réunion Description générale de la cohorte 117 patients ont été inclus

S. Rowe, S. Miller, and E. Sorscher, Cystic fibrosis, N Engl J Med, vol.352, 1992.

S. Moskowitz, J. Chmiel, D. Sternen, E. Cheng, G. Cutting et al., CFTR-Related Disorders, GeneReviews(®), 1993.

M. Rosenfeld, M. Sontag, and C. Ren, Cystic Fibrosis Diagnosis and Newborn Screening, Pediatric Clinics of North America, vol.63, issue.4, pp.599-615, 2016.
DOI : 10.1016/j.pcl.2016.04.004

D. Boeck and K. , Cystic fibrosis: terminology and diagnostic algorithms, Thorax, vol.61, issue.7, pp.627-635, 2006.
DOI : 10.1136/thx.2005.043539

G. Bellis, C. Dehillotte, and L. Lemonnier, Registre Français de La Mucoviscidose ? Bilan Des Données 2015, Vaincre La Mucoviscidose et Institut National d'études Démographiques (Ined), 2016.

G. Bellis, C. Dehillotte, and L. Lemonnier, Registre Français de La Mucoviscidose ? Bilan Des Données 2014, Vaincre La Mucoviscidose et Institut National d'études Démographiques (Ined), 2016.

B. Prentice, S. Hameed, C. Verge, C. Ooi, A. Jaffe et al., Diagnosing cystic fibrosis-related diabetes: current methods and challenges, Expert Review of Respiratory Medicine, vol.266, issue.1, pp.799-811, 2016.
DOI : 10.1016/j.jdiacomp.2014.06.012

A. Kelly and A. Moran, Update on cystic fibrosis-related diabetes, Journal of Cystic Fibrosis, vol.12, issue.4, pp.318-331, 2013.
DOI : 10.1016/j.jcf.2013.02.008

B. Nathan, T. Laguna, and A. Moran, Recent trends in cystic fibrosis-related diabetes, Current Opinion in Endocrinology, Diabetes and Obesity, vol.17, issue.4, pp.335-341, 2010.
DOI : 10.1097/MED.0b013e32833a780d

T. Ntimbane, B. Comte, and G. Mailhot, Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress, Clin Biochem Rev, vol.30, issue.4, p.153, 2009.

A. Olivier, Y. Yi, and X. Sun, Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets, Journal of Clinical Investigation, vol.122, issue.10, pp.3755-3768, 2012.
DOI : 10.1172/JCI60610DS1

M. Bellin, T. Laguna, and J. Leschyshyn, Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study, Pediatric Diabetes, vol.7, issue.Suppl 1, pp.417-421, 2013.
DOI : 10.1371/journal.pone.0039809

M. Hillman, L. Eriksson, L. Mared, K. Helgesson, and M. Landin-olsson, Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus, Journal of Cystic Fibrosis, vol.11, issue.2, pp.144-149, 2012.
DOI : 10.1016/j.jcf.2011.11.001

P. Kuo, J. Stevens, and A. Russo, Gastric Emptying, Incretin Hormone Secretion, and Postprandial Glycemia in Cystic Fibrosis???Effects of Pancreatic Enzyme Supplementation, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.5, pp.851-855, 2011.
DOI : 10.1210/jc.2010-2460

S. Lanng, A. Hansen, and B. Thorsteinsson, Glucose tolerance in patients with cystic fibrosis: five year prospective study, BMJ, vol.311, issue.7006, 1995.
DOI : 10.1136/bmj.311.7006.655

A. Moran, K. Pillay, D. Becker, and C. Acerini, Management of cystic fibrosis-related diabetes in children and adolescents, Pediatric Diabetes, vol.358, issue.Suppl. 677, pp.65-76, 2014.
DOI : 10.1056/NEJMoa0707943

S. Hameed, A. Jaffé, and C. Verge, Cystic Fibrosis Related Diabetes (CFRD)-The End Stage of Progressive Insulin Deficiency, Pediatric Pulmonology, vol.29, issue.8, pp.747-760, 2011.
DOI : 10.1007/BF03345538

F. Lombardo, D. Luca, F. Rosano, and M. , Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia, European Journal of Endocrinology, vol.149, issue.1, pp.53-59, 2003.
DOI : 10.1530/eje.0.1490053

K. Mohan, H. Miller, and P. Dyce, Mechanisms of glucose intolerance in cystic fibrosis, Diabetic Medicine, vol.311, issue.6, pp.582-588, 2009.
DOI : 10.1136/bmj.311.7006.655

A. Moran, K. Pyzdrowski, and J. Weinreb, Insulin Sensitivity in Cystic Fibrosis, Diabetes, vol.43, issue.8, pp.1020-1026, 1994.
DOI : 10.2337/diab.43.8.1020

K. Konrad, A. Thon, and M. Fritsch, Comparison of Cystic Fibrosis-Related Diabetes With Type 1 Diabetes Based on a

. German, Austrian Pediatric Diabetes Registry, Diabetes Care, vol.36, issue.4, pp.879-88610, 2013.

K. Konrad, N. Scheuing, and K. Badenhoop, Cystic fibrosis-related diabetes compared to type 1 and type 2 diabetes in adults, Diabetes/Metabolism Research and Reviews, 2013.
DOI : 10.1002/dmrr.2429

K. Konrad, T. Kapellen, and E. Lilienthal, Does ??-Cell Autoimmunity Play a Role in Cystic Fibrosis???Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry, Diabetes Care, vol.39, issue.8, pp.1338-134410, 2016.
DOI : 10.2337/dc16-0020

S. Blackman, S. Hsu, and S. Ritter, A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis, Diabetologia, vol.359, issue.13, pp.1858-1865, 2009.
DOI : 10.1186/1479-7364-2-1-67

S. Blackman, C. Commander, and C. Watson, Genetic Modifiers of Cystic Fibrosis-Related Diabetes, Diabetes, vol.62, issue.10, pp.3627-363510, 2013.
DOI : 10.2337/db13-0510

S. Lanng, B. Thorsteinsson, and F. Pociot, Diabetes mellitus in cystic fibrosis: genetic and immunological markers, Acta Paediatrica, vol.144, issue.2, pp.150-154, 1993.
DOI : 10.1007/BF00456124

S. Lanng, B. Thorsteinsson, C. Lund-andersen, J. Nerup, P. Schiøtz et al., Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications, Acta Paediatrica, vol.82, issue.1, pp.72-77, 1994.
DOI : 10.1007/BF01957574

A. Moran, J. Dunitz, B. Nathan, A. Saeed, B. Holme et al., Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality, Diabetes Care, vol.32, issue.9, pp.1626-163110, 2009.
DOI : 10.2337/dc09-0586

A. Adler, B. Shine, P. Chamnan, C. Haworth, and D. Bilton, Genetic Determinants and Epidemiology of Cystic Fibrosis-Related Diabetes: Results from a British cohort of children and adults, Diabetes Care, vol.31, issue.9, pp.1789-179410, 2008.
DOI : 10.2337/dc08-0466

M. Rana, C. Munns, and H. Selvadurai, Increased detection of cystic-fibrosis-related diabetes in Australia, Archives of Disease in Childhood, vol.96, issue.9, pp.823-826, 2011.
DOI : 10.1136/adc.2010.208652

B. Marshall, S. Butler, M. Stoddard, A. Moran, T. Liou et al., Epidemiology of cystic fibrosis-related diabetes, The Journal of Pediatrics, vol.146, issue.5, pp.681-687, 2005.
DOI : 10.1016/j.jpeds.2004.12.039

S. Finkelstein, C. Wielinski, and G. Elliott, Diabetes mellitus associated with cystic fibrosis, The Journal of Pediatrics, vol.112, issue.3, pp.373-377, 1988.
DOI : 10.1016/S0022-3476(88)80315-9

M. Geffner, B. Lippe, and S. Kaplan, Carbohydrate Tolerance in Cystic Fibrosis Is Closely Linked to Pancreatic Exocrine Function, Pediatric Research, vol.18, issue.11, pp.1107-1111, 1984.
DOI : 10.1203/00006450-198411000-00011

D. Soave, M. Miller, and K. Keenan, Evidence for a Causal Relationship Between Early Exocrine Pancreatic Disease and Cystic Fibrosis-Related Diabetes: A Mendelian Randomization Study, Diabetes, vol.63, issue.6, pp.2114-211910, 2014.
DOI : 10.2337/db13-1464

U. Herrmann, G. Dockter, and F. Lammert, Cystic fibrosis-associated liver disease, Best Practice & Research Clinical Gastroenterology, vol.24, issue.5, pp.585-592, 2010.
DOI : 10.1016/j.bpg.2010.08.003

M. Rowland, C. Gallagher, Ó. 'laoide, and R. , Outcome in Cystic Fibrosis Liver Disease, The American Journal of Gastroenterology, vol.89, issue.1, pp.104-109, 2011.
DOI : 10.1056/NEJMoa066359

H. White, K. Pollard, and C. Etherington, Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention, Journal of Cystic Fibrosis, vol.8, issue.3, pp.179-185, 2009.
DOI : 10.1016/j.jcf.2008.12.002

D. Hadjiliadis, J. Madill, and C. Chaparro, Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation*, Clinical Transplantation, vol.6, issue.6, pp.773-778, 2005.
DOI : 10.1164/ajrccm.163.1.9811076

O. Mondiale-de and L. Santé, Rapport Mondial Sur Le Diabète, 2016.

M. Craig, C. Jefferies, D. Dabelea, N. Balde, A. Seth et al., Definition, epidemiology, and classification of diabetes in children and adolescents, Pediatric Diabetes, vol.10, issue.Suppl. 4, pp.4-17, 2014.
DOI : 10.1515/JPEM.1997.10.3.283

. Haute-autorité-de-santé and . Mucoviscidose, Protocole national de diagnostic et de soins pour une maladie rare, 2006.

S. Hameed, J. Morton, and A. Jaffe, Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain, Diabetes Care, vol.33, issue.2, pp.221-22610, 2010.
DOI : 10.2337/dc09-1492

J. Brodsky, S. Dougherty, R. Makani, R. Rubenstein, and A. Kelly, Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis, Diabetes Care, vol.34, issue.2, pp.292-29510, 2011.
DOI : 10.2337/dc10-1604

R. Holl, C. Buck, C. Babka, A. Wolf, and A. Thon, HbA1c is not recommended as a screening test for diabetes in cystic fibrosis, Diabetes Care, vol.23, issue.1, p.126, 2000.
DOI : 10.2337/diacare.23.1.126b

J. Burgess, N. Bridges, and W. Banya, HbA1c as a screening tool for cystic fibrosis related diabetes, Journal of Cystic Fibrosis, vol.15, issue.2, pp.251-257, 2016.
DOI : 10.1016/j.jcf.2015.03.013

J. Widger, S. Hameed, C. Ooi, and C. Verge, Using HbA1c as a screening tool for Cystic Fibrosis Related Diabetes, Journal of Cystic Fibrosis, vol.15, issue.2, pp.263-264, 2016.
DOI : 10.1016/j.jcf.2015.10.009

A. Moran, C. Brunzell, and R. Cohen, Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, vol.33, issue.12, pp.2697-2708, 2010.
DOI : 10.2337/dc10-1768

O. Riordan, S. Robinson, P. Donaghue, K. Moran, and A. , Management of cystic fibrosis-related diabetes in children and adolescents, Pediatric Diabetes, vol.106, issue.Suppl1 OP 32, 0, pp.43-50, 2009.
DOI : 10.1097/01.AOG.0000172421.04007.74

O. Riordan, S. Hindmarsh, P. Hill, and N. , Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: A prospective cohort study, Diabetes Care, vol.32, issue.6, pp.1020-102210, 2009.
DOI : 10.2337/dc08-1925

L. Dobson, C. Sheldon, and A. Hattersley, Validation of Interstitial Fluid Continuous Glucose Monitoring in Cystic Fibrosis, Diabetes Care, vol.26, issue.6, pp.1940-1941, 2003.
DOI : 10.2337/diacare.26.6.1940-a

C. Jefferies, M. Solomon, K. Perlman, N. Sweezey, and D. Daneman, Continuous Glucose Monitoring in Adolescents with Cystic Fibrosis, The Journal of Pediatrics, vol.147, issue.3, 2005.
DOI : 10.1016/j.jpeds.2005.05.004

A. Khammar, N. Stremler, J. Dubus, G. Gross, J. Sarles et al., Holter glyc??mique et d??pistage du diab??te chez l???enfant atteint de mucoviscidose, Archives de P??diatrie, vol.16, issue.12, pp.1540-1546, 2009.
DOI : 10.1016/j.arcped.2009.09.007

A. Leclercq, B. Gauthier, and V. Rosner, Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients, Journal of Cystic Fibrosis, vol.13, issue.4, pp.478-484, 2014.
DOI : 10.1016/j.jcf.2013.11.005

F. Moreau, M. Weiller, and V. Rosner, Continuous Glucose Monitoring in Cystic Fibrosis Patients According to the Glucose Tolerance, Hormone and Metabolic Research, vol.40, issue.07, pp.502-506, 2008.
DOI : 10.1055/s-2008-1062723

C. Milla, W. Warwick, and A. Moran, Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.3, pp.891-895, 2000.
DOI : 10.1164/ajrccm.162.3.9904075

S. Lanng, B. Thorsteinsson, J. Nerup, and C. Koch, Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis, European Journal of Pediatrics, vol.727, issue.Suppl 1, pp.684-687, 1992.
DOI : 10.1007/BF01957574

C. Koch, M. Rainisio, and U. Madessani, Presence of cystic fibrosis???related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis, Pediatric Pulmonology, vol.32, issue.5, pp.343-350, 2001.
DOI : 10.1002/ppul.1142

E. Kerem, L. Viviani, and A. Zolin, Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry, European Respiratory Journal, vol.43, issue.1, pp.125-133, 2014.
DOI : 10.1183/09031936.00166412

A. Brennan, K. Gyi, and D. Wood, Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis, Journal of Cystic Fibrosis, vol.6, issue.2, 2007.
DOI : 10.1016/j.jcf.2006.03.009

M. Cheung, N. Bridges, and S. Prasad, Growth in children with cystic fibrosis-related diabetes, Pediatric Pulmonology, vol.90, issue.12, pp.1223-1225, 2009.
DOI : 10.1002/ppul.21127

R. Kraemer, A. Rüdeberg, B. Hadorn, and E. Rossi, RELATIVE UNDERWEIGHT IN CYSTIC FIBROSIS AND ITS PROGNOSTIC VALUE, Acta Paediatrica, vol.41, issue.1, pp.33-37, 1978.
DOI : 10.1016/0021-9681(75)90074-0

E. Bismuth, K. Laborde, and P. Taupin, Glucose Tolerance and Insulin Secretion, Morbidity, and Death in Patients with Cystic Fibrosis, The Journal of Pediatrics, vol.152, issue.4, 2008.
DOI : 10.1016/j.jpeds.2007.09.025

P. Chamnan, B. Shine, C. Haworth, D. Bilton, and A. Adler, Diabetes as a Determinant of Mortality in Cystic Fibrosis, Diabetes Care, vol.33, issue.2, pp.311-31610, 2010.
DOI : 10.2337/dc09-1215

G. Belle-van-meerkerk, E. Van-de-graaf, and J. Kwakkel-van-erp, Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases, Diabetic Medicine, vol.7, issue.8
DOI : 10.1111/j.1600-6143.2007.01749.x

M. Hofer, C. Schmid, and C. Benden, Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation, Journal of Cystic Fibrosis, vol.11, issue.2, pp.131-136, 2012.
DOI : 10.1016/j.jcf.2011.10.005

S. Schwarzenberg, W. Thomas, and T. Olsen, Microvascular Complications in Cystic Fibrosis-Related Diabetes, Diabetes Care, vol.30, issue.5, pp.1056-1061, 2007.
DOI : 10.2337/dc06-1576

S. Nousia-arvanitakis, A. Galli-tsinopoulou, and M. Karamouzis, Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus

S. Lanng, B. Thorsteinsson, J. Nerup, and C. Koch, Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections, Acta Paediatrica, vol.82, issue.8, pp.849-853, 1994.
DOI : 10.1007/BF02428297

L. Dobson, A. Hattersley, S. Tiley, S. Elworthy, P. Oades et al., Clinical improvement in cystic fibrosis with early insulin treatment, Archives of Disease in Childhood, vol.87, issue.5, pp.430-431, 2002.
DOI : 10.1136/adc.87.5.430

M. Rolon, K. Benali, and A. Munck, Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy, Acta Paediatr, vol.90, issue.8, pp.860-867, 2001.

R. Drummond, E. Ross, S. Bicknell, M. Small, and G. Jones, Insulin therapy in patients with cystic fibrosis related diabetes mellitus: benefit, timing of initiation and hypoglycaemia, Practical Diabetes International, vol.156, issue.4, pp.177-182, 2011.
DOI : 10.1530/eje.1.02344

G. Jones and C. Sainsbury, A Practical Approach to Glucose Abnormalities in Cystic Fibrosis, Diabetes Therapy, vol.6, issue.4, pp.611-620, 2016.
DOI : 10.1177/193229681200600507

E. Mozzillo, A. Franzese, and G. Valerio, One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements, Pediatric Diabetes, vol.147, issue.Suppl. 2, pp.162-167, 2009.
DOI : 10.1007/BF03345538

D. Hardin, J. Rice, M. Rice, and R. Rosenblatt, Use of the insulin pump in treat cystic fibrosis related diabetes, Journal of Cystic Fibrosis, vol.8, issue.3, 2009.
DOI : 10.1016/j.jcf.2008.12.001

N. Scheuing, K. Badenhoop, and M. Borkenstein, Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?, Pediatric Diabetes, vol.149, issue.1, pp.10-15, 2015.
DOI : 10.1007/s001120170107

G. Onady and A. Stolfi, Insulin and oral agents for managing cystic fibrosis-related diabetes In: The Cochrane Collaboration, Cochrane Database of Systematic Reviews

H. Jr, D. Mccoy, K. Sheikh, and S. , Resolution of Cystic Fibrosis?related Diabetes with Ivacaftor Therapy, Am J Respir Crit Care Med, vol.190, issue.5, pp.590-591, 2014.

M. Rewers, K. Pillay, and C. De-beaufort, Assessment and monitoring of glycemic control in children and adolescents with??diabetes, Pediatric Diabetes, vol.2, issue.1 Pt 1, pp.102-114, 2014.
DOI : 10.1016/S2213-8587(13)70199-2

A. Brennan, K. Gyi, D. Wood, M. Hodson, D. Geddes et al., Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis, Journal of Cystic Fibrosis, vol.5, issue.1, pp.27-31, 2006.
DOI : 10.1016/j.jcf.2005.09.001

H. Flodrops, M. Renouil, and F. Lesure, Aspects cliniques et sp??cificit??s g??n??tiques de la mucoviscidose ?? l?????le de la R??union, Archives de P??diatrie, vol.10, issue.11, pp.955-959, 2003.
DOI : 10.1016/j.arcped.2003.09.008

F. Cartault, J. Steffann, and D. Vidaud, Detection of more than 91% cystic fibrosis mutations in a sample of the population from Reunion Island and identification of two novel mutations (A309G, S1255L) and one novel polymorphism (L49L), Clin Genet, vol.54, issue.5, pp.437-439, 1998.

T. Bienvenu, M. Viel, C. Leroy, F. Cartault, J. Lesure et al., Spectrum of CFTR Mutations on Reunion Island: Effect of Neonatal Screening, Human Biology, vol.77, issue.5, pp.705-714, 2005.
DOI : 10.1353/hub.2006.0002

F. Favier, I. Jaussent, and N. Moullec, Prevalence of Type 2 diabetes and central adiposity in La R??union Island, the REDIA Study, Diabetes Research and Clinical Practice, vol.67, issue.3, pp.234-242, 2005.
DOI : 10.1016/j.diabres.2004.07.013

A. Tezier, Diabète à l'âge pédiatrique à la Réunion : description des caractéristiques cliniques